Business news with perspective

Beyond the bar, Campari's Red Hands competition is a masterclass in corporate strategy, building a talent pipeline and brand loyalty across Asia-Pacific.

A novel drug designed by AI to prevent a crippling side effect of chemotherapy has received dual US and Taiwan regulatory approval, paving the way for human trials.

The Philippines' largest bookseller partners with Anchanto to unify its 260+ stores and online channels, signaling a major shift in Southeast Asian retail.

Beyond oil, Abu Dhabi is building a global life sciences hub. A new partnership with Sanofi to create a Vaccine Innovation Centre is its boldest move yet.

Suburban Water Systems replaces a century-old reservoir with seismic-ready steel, tackling California's dual threats of earthquakes and power outages.

The new SLATE technology stacks silicon wafers vertically, promising up to 45% smaller RF components for sleeker, more power-efficient smartphones and beyond.

A new White House order sets a firm timeline for quantum-safe security. With data already being harvested for future decryption, the race against 'Q-Day' is on.

A new White House order accelerates the shift to quantum-proof security. Can industry upgrade its digital defenses before 'Q-Day' renders them obsolete?

Rentokil Terminix is betting on data, not just chemicals, to win the pest control war. How smart sensors and Google bookings are changing an age-old industry.

A novel drug aims to reverse myelin damage in MS, a feat no current therapy can achieve. But with a recent FDA hold, is Quantum BioPharma's vision a breakthrough or a mirage?

A new partnership puts high-purity recycled plastic in food containers, a breakthrough that helps brands meet tough new laws and growing consumer demand.

A Canadian biotech is developing a novel cancer drug. We look beyond the paid promotions to analyze the science, the strategy, and the high-stakes reality.

As quantum threats loom, SEALSQ is set to unveil its U.S. roadmap for hardware-based security, a critical move for national defense and supply chains.

NewtekOne just automated a tedious part of getting a business loan. But the real story is its plan to sell this tech to other banks, changing its own game.

As autonomous AI agents multiply, creating chaos and risk, a new class of governance is emerging. A key partnership shows how enterprises can regain control.

A new report reveals a fractured U.S. housing landscape. While most of the nation sees buyer power grow, tech booms are fueling fierce bidding wars in others.

Quoin Pharma's new drug name is a key step, but the path to the first-ever treatment for a rare skin disease reveals the complex interplay of innovation and finance.

With 4K laser projectors at 50% off, Dangbei is betting big that consumers will ditch the TV for a massive, cinematic experience that disappears on command.

SRX Global's investment in ARMR Sciences' long-lasting fentanyl countermeasure signals a paradigm shift from reactive treatment to proactive biodefense.

A Bitcoin miner is betting its future on AI, repurposing its power grid to chase the tech industry's insatiable demand for energy. Is this the new blueprint?